ApoCell Receives $2.9M Grant to Develop CTC Detection Platform for NCI | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ApoCell said Wednesday that it has been awarded a $2.9 million contract by SAIC-Frederick to develop and deliver 12 alpha prototype units of ApoCell's circulating tumor cell detection system.

The order from SAIC-Frederick, in support of the National Cancer Institute, is the first commercial order for the system called ApoStream. ApoCell said it expects to deliver the units to SAIC-Frederick in early 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.